Formats: Text / Subjects: Biosimilar Pharmaceuticals and Cost Savings - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Subjects Biosimilar Pharmaceuticals ✖ Subjects Cost Savings ✖

1. State biosimilar substitution laws could reduce consumer access and savings

Author(s):: Purvis, Leigh, author
McSpadden, James, author
Publication:: Washington, DC : AARP Public Policy Institute, October 2022
Subject(s):: Biosimilar Pharmaceuticals
Cost Savings
Health Services Accessibility
Legislation, Drug
Drug Costs
State Government
United States

2. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):: Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
Access to Information
Biosimilar Pharmaceuticals
Commerce
Conflict of Interest
Drug Industry
Insurance, Pharmaceutical Services
Managed Care Programs
Medicaid -- economics
Medicare Part D -- economics
Patents as Topic
State Government
Humans
United States